Last updated: December 4, 2023
Sponsor: Oslo University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neck Pain
Chronic Pain
Treatment
Radiofrequency neurotomy
Sham treatment
Clinical Study ID
NCT03066960
2015/2194
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
- Min 18 years and Maximum 80 years
- Read and understand Norwegian
- Stable neck pain >12 months, with or without unilateral headache
- Average of worst pain intensity last three days ≥ 4 out of maximum 10
- Neck Disability Index >15 points or > 30 percentage points.
- At least two predictive blocks ≥ 50% pain relief 30 to 60 minutes after lidocaine and 30 to 180 minutes after bupivacaine .
Exclusion
Exclusion Criteria:
- Serious cervical pathology (acute cervical disc herniation, radiculopathy, myelopathy,spinal anomalies and chronic widespread pain
- Opioid consumption > 50 morphine equivalents/day
- Ongoing litigation process and applying for disability insurance/benefits
- Serious psychiatric disorder (DSM-IV-TR) diagnosed at a psychiatric unit, includingsuicidal thoughts and somatization (from Hopkins Symptom Check List 25 ≥ 2.5)
- Ongoing addictive behavior ( diagnostic criteria in Statistical Manual, 4th Edition)
- Unstable medical condition (ASA 4, serious vascular disease like unstable angina)
- Bacterial infection
- Malignancy
- Chronic generalized pain
- Hypersensitive to contrast agents or local anesthetics
- Pregnancy
- Bleeding diathesis
- Previously radiofrequency neurotomy
Study Design
Total Participants: 34
Treatment Group(s): 2
Primary Treatment: Radiofrequency neurotomy
Phase:
Study Start date:
January 01, 2019
Estimated Completion Date:
December 14, 2025
Study Description
Connect with a study center
Department for Pain and Complex Disorders
Trondheim, Torgarden 3250
NorwayActive - Recruiting
Department of Pain Management and Research Oslo University Hospital
Oslo, 4950
NorwayActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.